Elon Musk cheered the FDA's approval for brain-implant company Neuralink to start testing the tech on humans, but some were not keen on the clinical study.

Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.

Neuralink, Elon Musk’s brain implant company, announced Thursday night that its first human trial has been approved by the Food and Drug Administration. “This is the result of incredible work ...

Elon Musk’s Neuralink is conducting its first human clinical trial of a brain implant. We VERIFY how the FDA process for studies like this works.

Elon Musk's brain-implant company Neuralink says it has received a green light from the US Food and Drug Administration (FDA) to kickstart its first-in-human clinical study, a critical milestone ...

The agency claims Whoop is marketing an unauthorized medical device intended to diagnose, cure, treat or prevent a disease.

Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Neuralink received FDA approval for its first human study in May 2023. The company had expressed on Twitter that this approval marks a crucial initial step towards utilising its technology to aid ...

Neuralink’s Blindsight has received the breakthrough device designation from the FDA, which signifies its potential to offer a significant advancement in treating or diagnosing life-threatening or ...

The brain-chip startup of Elon Musk's Neuralink has now announced Blindsight - an experimental vision-restoring implant - which will attempt to give vision to the blind.